CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Evofem Biosciences Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Evofem Biosciences Inc
12400 High Bluff Dr Ste 600
Phone: (858) 550-1900p:858 550-1900 SAN DIEGO, CA  92130-3077  United States Ticker: EVFMEVFM

Business Summary
Evofem Biosciences Inc, formerly Neothetics, Inc., is a clinical-stage specialty biopharmaceutical company. The Company develops products to address unmet needs in women's sexual and reproductive health. The Company’s product Amphora, is a Multipurpose Vaginal pH Regulator (MVP-R) designed to regulate vaginal pH to within the normal range of 3.5 to 4.5 even in the presence of semen. This maintains an acidic environment which is inhospitable to sperm as well as certain viral and bacterial pathogens associated with sexually transmitted infections. Amphora is used to prevent urogenital chlamydia and gonorrhea in women. The Company is in the second Phase III clinical trial of Amphora for prevention of pregnancy (AMP002). The Company is currently designing a Phase IIb trial for its second product candidate, a MVP-R to reduce the recurrence of bacterial vaginosis.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
IRA CQ
Score
Moody's
Rating
Fitch
Rating
DBRS
Rating
Morningstar
Rating
YesYes-------

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/201912/31/2018YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chief Executive Officer SaundraPelletier 1/17/2018 1/17/2018
Chief Financial Officer Justin J.File 1/17/2018 1/17/2018
Vice President, Clinical Operations, Regulatory Affairs and Quality Assurance MariaFeldman 52 2/1/2016 2/1/2016
5 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Evofem Biosciences Operations Inc 12400 High Bluff Dr Ste 600 SAN DIEGO CA United States

Business Names
Business Name
EVFM
Evofem Biosciences Operations Inc.
Evofem Limited, LLC
5 additional Business Names available in full report.

General Information
Number of Employees: 30 (As of 2/22/2019)
Outstanding Shares: 46,810,803 (As of 10/31/2019)
Shareholders: 25
Stock Exchange: NASD
Federal Tax Id: 208527075
Fax Number: (858) 750-1013
Email Address: info@neothetics.com


Copyright © 2019 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, December 07, 2019